Oppenheimer Maintains Outperform on Centene

Oppenheimer is out with its report today on Centene CNC, maintaining Outperform. In a note to clients, Oppenheimer writes, "CNC's business remains on track, as the RFP pipeline remains robust and utilization continues to trend modestly. Although rate increases are likely to remain low, the company should continue to identify additional cost saving opportunities to keep margins intact. As a result, we reiterate our Outperform rating." Oppenheimer maintains a $40 PT on CNC. Shares of CNC closed Tuesday at $33.95.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsCenteneHealth CareManaged Health CareOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!